Zinterol hydrochloride

Discontinued Product

1051 has been discontinued.

View all Adrenergic &beta;<sub>2</sub> Receptors products.
Description: Selective β2 agonist
Alternative Names: MJ 9184
Chemical Name: N-[5-[2-[(1,1-Dimethyl-2-phenylethyl)amino]-1-hydroxyethyl]-2-hydroxyphenyl]methanesulphonamide hydrochloride
Purity: ≥98% (HPLC)
Datasheet
Citations (4)
Reviews
Literature (1)

Biological Activity for Zinterol hydrochloride

Zinterol hydrochloride is a potent and selective β2-adrenoceptor agonist (pKB values are 8.3 and < 5.7 for β 2 and β1 receptors respectively, as measured in human artery).

Technical Data for Zinterol hydrochloride

M. Wt 414.95
Formula C19H26N2O4S.HCl
Storage Store at +4°C
Purity ≥98% (HPLC)
CAS Number 38241-28-0
PubChem ID 37989
InChI Key LVNUBJDWJFOMKH-UHFFFAOYSA-N
Smiles OC1=C(NS(=O)(C)=O)C=C(C(O)CNC(C)(C)CC2=CC=CC=C2)C=C1.Cl

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for Zinterol hydrochloride

Certificate of Analysis / Product Datasheet
Select another batch:

References for Zinterol hydrochloride

References are publications that support the biological activity of the product.

Arvydas Skeberdis et al (1997) Beta-2 adrenergic activation of L-type Ca2+ current in cardiac myocytes. J.Pharmacol.Exp.Ther. 283 452 PMID: 9353357

Hutchinson et al (2006) Agonist effects of zinterol at the mouse and human β3-adrenoceptor. Naunyn Schmiedebergs Arch.Pharmacol. 373 158 PMID: 16601951

Kauman (1997) Four β-adrenoceptor subtypes in the mammalian heart. TiPS 18 70 PMID: 9133774

View Related Products by Target

View Related Products by Product Action

View all Adrenergic β2 Receptor Agonists

Keywords: Zinterol hydrochloride, Zinterol hydrochloride supplier, Selective, α2-adrenoceptor, beta2-adrenoceptor, b2-adrenoceptor, β2-adrenergic, α2-adrenergic, beta2-adrenergic, b2-adrenergic, agonists, Receptors, MJ9184, MJ, 9184, Adrenergic, Beta-2, 1051, Tocris Bioscience

4 Citations for Zinterol hydrochloride

Citations are publications that use Tocris products. Selected citations for Zinterol hydrochloride include:

Macdougall et al (2012) Caveolae compartmentalise β2-adrenoceptor signals by curtailing cAMP production and maintaining phosphatase activity in the sarcoplasmic reticulum of the adult ventricular myocyte. J Mol Cell Cardiol 52 388 PMID: 21740911

Huang et al (2018) ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure. Cell Discov 4 57 PMID: 30374408

Eckle et al (2008) A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Am Coll Cardiol 118 3301 PMID: 18787641

Schutsky et al (2011) Stress and glucocorticoids impair memory retrieval via β2-adrenergic, Gi/o-coupled suppression of cAMP signaling. J Neurosci 31 14172 PMID: 21976502


Reviews for Zinterol hydrochloride

There are currently no reviews for this product. Be the first to review Zinterol hydrochloride and earn rewards!

Have you used Zinterol hydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.